Prolonged Adjuvant Temozolomide vs "Stop & Go" in Glioblastoma Patients

NCT00643825 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

64

Enrollment

OTHER

Sponsor class

Conditions

Glioblastoma

Interventions

DRUG: Temozolomide
DRUG: Temozolomide

Sponsor

Cliniques universitaires Saint-Luc- Université Catholique de Louvain